治験サプライの世界市場：製品/サービス（物流/流通、製造、包装、ラベリング）、治験フェーズ、治療分野別分析...市場調査レポートについてご紹介

1 Introduction (Page No. – 14)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Market Segmentation
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology (Page No. – 17)
2.1 Market Size Estimation
2.2 Market Breakdown and Data Triangulation
2.3 Market Share Estimation
2.3.1 Key Data From Secondary Sources
2.3.2 Key Data From Primary Sources
2.3.3 Key Industry Insights
2.4 Assumptions for the Study

3 Executive Summary (Page No. – 25)

4 Premium Insights (Page No. – 30)
4.1 Clinical Trial Supplies Market
4.2 Market Share, Services vs Regions
4.3 Geographic Analysis: Clinical Trial Supplies Market, By Phase
4.4 Geographic Analysis: Market, By Product
4.5 Lifecycle Analysis, By Region

5 Market Overview (Page No. – 35)
5.1 Introduction
5.2 Clinical Trial Supplies: Market Segmentation
5.2.1 By Products and Services
5.2.2 By Phase
5.2.3 By Therapeutic Area
5.2.4 By Region
5.3 Market Dynamics
5.3.1 Market Drivers
5.3.1.1 Globalization of Clinical Trial Activities
5.3.1.2 Increasing R&D Investments and Government Support
5.3.1.3 Rising Incidences of Various Diseases
5.3.1.4 Increasing Expansion Activities By Cros
5.3.2 Market Restrains
5.3.2.1 Longer Approval Times for Clinical Trials
5.3.3 Opportunities
5.3.3.1 Emerging Markets
5.3.3.2 Increasing Number of Patent Expirations and Development of Generic Drugs
5.4 Industry Trends
5.4.1 Just–In-Time Packaging and Labeling Methods for Clinical Trial Supplies

6 Clinical Trial Supplies Market, By Product and Service (Page No. – 43)
6.1 Introduction
6.2 Manufacturing
6.3 Packaging and Labeling
6.4 Logistics and Distribution

7 Clinical Trial Supplies Market, By Phase (Page No. – 55)
7.1 Introduction
7.2 Phase I
7.3 Phase II
7.4 Phase III and Bioequivalence Studies

8 Clinical Trial Supplies Market, By Therapeutic Area (Page No. – 62)
8.1 Introduction
8.2 Oncology
8.3 Cns and Mental Disorders
8.4 Cardiovascular Diseases
8.5 Infectious Diseases
8.6 Respiratory Diseases
8.7 Blood Disorders
8.8 Dermatology
8.9 Others

9 Clinical Trial Supplies Market, By Region (Page No. – 74)
9.1 Introduction
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 U.K.
9.3.2 Germany
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Rest of Europe (Roe)
9.4 Asia-Pacific
9.4.1 China
9.4.2 India
9.4.3 Japan
9.4.4 Rest of Asia-Pacific (RoAPAC)
9.5 Rest of the World (RoW)

10 Competitive Landscape (Page No. – 101)
10.1 Overview
10.2 Market Share Analysis
10.3 Competitive Situations and Trends
10.3.1 Expansion
10.3.2 Agreements, Partnerships, Collaborations, and Joint Venture
10.3.3 Acquisitions
10.3.4 New Product and Service Launches
10.3.5 Others

11 Company Profiles (Page No. – 108)
(Overview, Financials, Products & Services, and Developments)*
11.1 Introduction
11.2 ALMAC Group Ltd,
11.3 Catalent Pharma Solutions, Inc.
11.4 Parexel International
11.5 Thermo Fisher Scientific, Inc.
11.6 PCI Services
11.7 Patheon, Inc.
11.8 Sharp Packaging Services
11.9 Biocair
11.10 Movianto
11.11 Klifo A/S.

*Details on Overview, Financials, Product & Services, and Developments Might Not Be Captured in Case of Unlisted Companies.

12 Appendix (Page No. – 128)
12.1 Insights of Industry Experts
12.2 Discussion Guide
12.3 Introducing RT: Real-Time Market Intelligence
12.4 Available Customizations
12.5 Related Reports